ASCO Annual Meeting 2021 - Biognosys
Contact us Helpdesk

ASCO Annual Meeting 2021


At this year’s ASCO Virtual Annual Meeting, Biognosys is proud to present two abstracts, highlighting our work with IRCCS Istituto Nazionale Tumori Fondazione G Pascale, Napoli, Italy, and Indivumed, we demonstrate the utility of our next-generation proteomics platform to advance the understanding of cancer biology and identify novel biomarkers and therapeutic targets in oncology clinical research:

Biognosys' Abstracts at the Virtual ASCO Annual Conference 2021

“Proteomics Meets Transcriptomics: Identification of Tumor Tissue Signatures Specific to anti-PD1 Treatment in Late-stage Melanoma Patients”

“Proteome and Phospho-proteome Profiling for Deeper Phenotype Characterization of Colorectal Cancer Heterogeneity”


Publication Only: Melanoma/Skin Cancers



Kamil Sklodowski, Domenico Mallardo, Jakob Vowinckel, Mariaelena Capone, Martin Soste, Gabriele Madonna, Vito Vanella, Sarah Warren, Paolo Antonio Ascierto;

Biognosys AG, Schlieren, Switzerland; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori–Fondazione “G. Pascale”, Naples, Italy; Biognosys, Schlieren, Switzerland; Istituto Nazionale Tumori Pascale, Naples, Italy; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori-IRCCS Fondazione “G. Pascale”, Naples, Italy; Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy; NanoString Technologies, Inc., Seattle, WA

Abstract e21543


Publication Only: Gastrointestinal Cancer – Colorectal and Anal



Jakob Vowinckel, Thomas Corwin, Jonathan Woodsmith, Tobias Treiber, Roland Bruderer, Lukas Reiter, Eike-Christin von Leitner, Karel Novy, Hartmut Juhl, Oliver Rinner, Indivumed Authors;

Biognosys, Schlieren, Switzerland; INDIVUMED GMBH, Hamburg, Germany; Biognosys, Zurich, Switzerland; Indivumed GmbH, Hamburg, Germany

Abstract e15536